Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Rankning i aktier #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Aktiekurs
$44.42
Senast synkroniserad: 2026-08-25
Marknadsvärde
$5.90B
Förändring (1 dag)
2.66%
Förändring (1 år)
344.66%
Land
US
Handel Definium Therapeutics, Inc. (DFTX)

Kategori

Historik för aktiesplit för Definium Therapeutics, Inc. (DFTX)
Aktien Definium Therapeutics, Inc. (symbol: DFTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 26, 2026.
En DFTX-aktie köpt före Aug 26, 2026 motsvarar nu 0 DFTX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH